306 related articles for article (PubMed ID: 17182012)
21. Frontal dopaminergic abnormality in Tourette syndrome: a postmortem analysis.
Yoon DY; Gause CD; Leckman JF; Singer HS
J Neurol Sci; 2007 Apr; 255(1-2):50-6. PubMed ID: 17337006
[TBL] [Abstract][Full Text] [Related]
22. Aberrant expression of metabotropic glutamate receptor 2 in the vulnerable neurons of Alzheimer's disease.
Lee HG; Ogawa O; Zhu X; O'Neill MJ; Petersen RB; Castellani RJ; Ghanbari H; Perry G; Smith MA
Acta Neuropathol; 2004 Apr; 107(4):365-71. PubMed ID: 14872255
[TBL] [Abstract][Full Text] [Related]
23. Different effects of five dopamine receptor subtypes on nuclear factor-kappaB activity in NG108-15 cells and mouse brain.
Takeuchi Y; Fukunaga K
J Neurochem; 2004 Jan; 88(1):41-50. PubMed ID: 14675148
[TBL] [Abstract][Full Text] [Related]
24. Current drug treatments targeting dopamine D3 receptor.
Leggio GM; Bucolo C; Platania CB; Salomone S; Drago F
Pharmacol Ther; 2016 Sep; 165():164-77. PubMed ID: 27343365
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical localization of tissue factor pathway inhibitor-1 (TFPI-1), a Kunitz proteinase inhibitor, in Alzheimer's disease.
Hollister RD; Kisiel W; Hyman BT
Brain Res; 1996 Jul; 728(1):13-9. PubMed ID: 8864292
[TBL] [Abstract][Full Text] [Related]
26. Expression of Somatostatin, cortistatin, and their receptors, as well as dopamine receptors, but not of neprilysin, are reduced in the temporal lobe of Alzheimer's disease patients.
Gahete MD; Rubio A; Durán-Prado M; Avila J; Luque RM; Castaño JP
J Alzheimers Dis; 2010; 20(2):465-75. PubMed ID: 20164562
[TBL] [Abstract][Full Text] [Related]
27. Role of dopamine D3 receptors in methamphetamine-induced behavioural sensitization and the characterization of dopamine receptors (D1R-D5R) gene expression in the brain.
Su H; Wang X; Bai J; Fan Y; Du Y; Wei Z; Yan J; Yun K; Chen T
Folia Neuropathol; 2022; 60(1):105-113. PubMed ID: 35359150
[TBL] [Abstract][Full Text] [Related]
28. Role of the fourth intracellular loop of D1-like dopaminergic receptors in conferring subtype-specific signaling properties.
Tumova K; Zhang D; Tiberi M
FEBS Lett; 2004 Oct; 576(3):461-7. PubMed ID: 15498581
[TBL] [Abstract][Full Text] [Related]
29. Changes of neurocalcin, a calcium-binding protein, in the brain of patients with Alzheimer's disease.
Shimohama S; Chachin M; Taniguchi T; Hidaka H; Kimura J
Brain Res; 1996 Apr; 716(1-2):233-6. PubMed ID: 8738246
[TBL] [Abstract][Full Text] [Related]
30. Dopamine receptor subtypes in the human pulmonary arterial tree.
Ricci A; Mignini F; Tomassoni D; Amenta F
Auton Autacoid Pharmacol; 2006 Oct; 26(4):361-9. PubMed ID: 16968475
[TBL] [Abstract][Full Text] [Related]
31. Expression of somatostatin receptor subtypes (SSTR1-5) in Alzheimer's disease brain: an immunohistochemical analysis.
Kumar U
Neuroscience; 2005; 134(2):525-38. PubMed ID: 15961235
[TBL] [Abstract][Full Text] [Related]
32. Upregulation of renal D5 dopamine receptor ameliorates the hypertension in D3 dopamine receptor-deficient mice.
Wang X; Escano CS; Asico L; Jones JE; Barte A; Lau YS; Jose PA; Armando I
Hypertension; 2013 Aug; 62(2):295-301. PubMed ID: 23753418
[TBL] [Abstract][Full Text] [Related]
33. Motor inhibitory role of dopamine D1 receptors: implications for ADHD.
Heijtz RD; Kolb B; Forssberg H
Physiol Behav; 2007 Sep; 92(1-2):155-60. PubMed ID: 17585966
[TBL] [Abstract][Full Text] [Related]
34. Dopamine, vesicular transporters and dopamine receptor expression and localization in rat thymus and spleen.
Mignini F; Tomassoni D; Traini E; Amenta F
J Neuroimmunol; 2009 Jan; 206(1-2):5-13. PubMed ID: 19012970
[TBL] [Abstract][Full Text] [Related]
35. Enhanced expression of 14-3-3 proteins in reactive astrocytes in Creutzfeldt-Jakob disease brains.
Kawamoto Y; Akiguchi I; Jarius C; Budka H
Acta Neuropathol; 2004 Oct; 108(4):302-8. PubMed ID: 15235801
[TBL] [Abstract][Full Text] [Related]
36. Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson's disease.
Ferrer I; Perez E; Dalfó E; Barrachina M
Neurosci Lett; 2007 Mar; 415(3):205-9. PubMed ID: 17284347
[TBL] [Abstract][Full Text] [Related]
37. Dopamine receptors in equine ovarian tissues.
King SS; Campbell AG; Dille EA; Roser JF; Murphy LL; Jones KL
Domest Anim Endocrinol; 2005 May; 28(4):405-15. PubMed ID: 15826775
[TBL] [Abstract][Full Text] [Related]
38. Postnatal alterations in dopaminergic markers in the human prefrontal cortex.
Weickert CS; Webster MJ; Gondipalli P; Rothmond D; Fatula RJ; Herman MM; Kleinman JE; Akil M
Neuroscience; 2007 Feb; 144(3):1109-19. PubMed ID: 17123740
[TBL] [Abstract][Full Text] [Related]
39. Neuroendocrine-specific protein C, a marker of neuronal differentiation, is reduced in brain of patients with Down syndrome and Alzheimer's disease.
Kim SH; Yoo BC; Broers JL; Cairns N; Lubec G
Biochem Biophys Res Commun; 2000 Sep; 276(1):329-34. PubMed ID: 11006125
[TBL] [Abstract][Full Text] [Related]
40. Disturbances in neurotransmission processes in aging and age-related diseases.
Ossowska K
Pol J Pharmacol; 1993; 45(2):109-31. PubMed ID: 8401765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
